Today we're taking a look at an index that often gets ignored. The Value Line Geometric Index is currently flirting with a multi-decade breakout. This is an equally weighted index using a geometric average, so the daily change is closest to the median stock price change. It's a much broader measure of the market vs something like the Dow Jones Industrial Average. 

It's my favorite exercise each month. There is nothing else I do throughout my entire process that provides as much value as my Monthly Chart Review. Here's what stood out to me this month:

Let's start with Papa Dow. The Dow Jones Industrial Average has gone nowhere for 20 months. Flat for over a year and a half:

Click on Charts To Zoom In

It's that time of the cycle where we begin to evaluate our open positions that are soon expiring. We had a number of September expiration trades that have already closed -- either because their profit target was achieved ($XLB $XLE) or their stop loss level was violated ($AVGO $CSX $HFC $XLY), but we still have four open positions that require our attention as the calendar transitions to September.

We'll talk more about these in our upcoming monthly All Star Options conference call, but I'll give you a head start on our current thinking here:

From the desk of Tom Bruni @BruniCharting

Tuesday's Mystery Chart is one of my favorite charts right now, so thank you all for your feedback and participation.

Everyone was on the same page here, waiting for a resolution before getting involved. Sometimes nothing is the best answer, that's why it's one of the choices.

With that as our backdrop, let's get into it.

This could be a major top in the US Stock Market. It could be a historic top like 2007 or 1929, maybe even 1987. This is certainly a possible outcome.

Something else to consider is that betting on these outcomes is rarely a profitable endeavor. They make movies about the heroes who bet heavily on the financial collapse of 2008 and made fortunes. We talk about these fund managers like legends. What they don't make movies about are the infinite number of investors over the years who have bet on such outcomes, and were wrong instead. I guess Hollywood doesn't think those stories will sell.

I understand the bearish thesis for US Stocks. In fact, we always take the other side of our opinions and try to poke wholes in a given theme. We've been in the camp that since most stocks have gone down to sideways over the past 19 months, this is a classic cyclical bear market. It has gone on through both price and time, not just one of the two. I don't care how you slice it, this was a bear market, and possibly still is.

From the desk of Tom Bruni @BruniCharting

New Mystery Chart!

For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or relative basis. Maybe it's a custom index or inverted, who knows!

We do all this to put aside the biases we have associated with this specific security/the market and come to a conclusion based solely on price.

You can guess what it is if you must, but the real value comes from sharing what you would do right now. Buy, Sell, or Do Nothing?

In this Episode of Allstarcharts Weekly, Steve and I talk the relative performance of stocks. When assets are in strong uptrends, they not only perform on an absolute basis, but they tend to outperform their alternatives. With new highs in the S&P500 last month, we've seen nothing but lower highs relative to both Gold and US Treasury Bonds. In fact, on a relative basis, the S&P500 is actually down to its late December 2018 lows. Will they hold or confirm a massive distributive top? I think the resolution will tell us a lot about the strength of the current stock market.

When I go through my charts, I see all kinds of different trends, patterns and consolidations around the world. It really depends on what I'm looking at. However, one area that has been a consistent outperformer is in Medical Device stocks. The way I see it, these are just Tech stocks stuck in the bodies of Healthcare names. So our theme of "bullish tech" makes sense, even though on paper they're Healthcare stocks. 

Here is a chart of the Medical Device & Equipment Index $IHI relative to the S&P500. This one goes from the lower left to the upper right. We call those Uptrends:

From the desk of Tom Bruni @BruniCharting

In early July we were looking at some divergences that were signaling a potential short-term bottom in US Interest Rates.

That thesis was quickly proven wrong as global yields pulled the US down with them, and last week in our Conference Call we discussed our current outlook for Bonds and their many intermarket relationships.

Earlier this week JC discussed the fact that Bonds are at an interesting level relative to the S&P 500 as well.

Yesterday I discussed some of the pitfalls to avoid when using Bond ETFs as a proxy for the underlying assets.

Needless to say, we've been talking a lot about Bonds.

In this post, I'm going to take a simplified look at price action and momentum of the 2, 5, 10, and 30-Year Treasuries to assess the reward/risk and if there's a short-term trading opportunity at current levels.

From the desk of Tom Bruni @BruniCharting

Tuesday's Mystery Chart is one of my favorite charts right now, so thank you all for your feedback and participation.

Almost every one of you said you were selling the stock in question as it put in a failed breakout, while a handful of you were doing nothing and buying the subsequent breakout with me.

With that as our backdrop, let's get into it.

From the desk of Tom Bruni @BruniCharting

This week I've seen a chart of High Yield relative to Investment Grade Bonds floating around with various conclusions, but I wanted to use this to highlight some things to consider when using Bond ETFs as a proxy for what's happening in the market it's meant to track.